Colloidal semiconductor nanocrystals are widely used as lumiphores in biological imaging because their luminescence is both strong and stable, and because they can be biofunctionalized. During synthesis, nanocrystals are typically passivated with hydrophobic organic ligands 1 , so it is then necessary either to replace these ligands or encapsulate the nanocrystals with hydrophilic moieties to make the lumiphores soluble in water. Finally, biological labels must be added to allow the detection of nucleic acids, proteins and specific cell types 2-8 . This multistep process is time-and labour-intensive and thus out of reach of many researchers who want to use luminescent nanocrystals as customized lumiphores. Here, we show that a single designer ligand-a chimeric DNA molecule-can controllably program both the growth and the biofunctionalization of the nanocrystals. One part of the DNA sequence controls the nanocrystal passivation and serves as a ligand, while another part controls the biorecognition. The synthetic protocol reported here is straightforward and produces a homogeneous dispersion of nanocrystal lumiphores functionalized with a single biomolecular receptor. The nanocrystals exhibit strong optical emission in the visible region, minimal toxicity and have hydrodynamic diameters of 6 nm, which makes them suitable for bioimaging 4 . We show that the nanocrystals can specifically bind DNA, proteins or cells that have unique surface recognition markers.
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, so it is then necessary either to replace these ligands or encapsulate the nanocrystals with hydrophilic moieties to make the lumiphores soluble in water. Finally, biological labels must be added to allow the detection of nucleic acids, proteins and specific cell types [2] [3] [4] [5] [6] [7] [8] . This multistep process is time-and labour-intensive and thus out of reach of many researchers who want to use luminescent nanocrystals as customized lumiphores. Here, we show that a single designer ligand-a chimeric DNA molecule-can controllably program both the growth and the biofunctionalization of the nanocrystals. One part of the DNA sequence controls the nanocrystal passivation and serves as a ligand, while another part controls the biorecognition. The synthetic protocol reported here is straightforward and produces a homogeneous dispersion of nanocrystal lumiphores functionalized with a single biomolecular receptor. The nanocrystals exhibit strong optical emission in the visible region, minimal toxicity and have hydrodynamic diameters of 6 nm, which makes them suitable for bioimaging 4 . We show that the nanocrystals can specifically bind DNA, proteins or cells that have unique surface recognition markers.
DNA is well suited to the task of producing customized nanocrystal lumiphores because it is known to serve as a receptor for molecular recognition 9 and as an inert nanocrystal passivator [10] [11] [12] [13] [14] [15] . Both nucleic acids sequence and structure have been used to control the properties of lead-and cadmium-containing nanocrystals 13, 14 , and the materials made in this way have been shown to have low cellular toxicity and good properties for cellular imaging 13 . However, little has been done to functionalize these materials to enable versatile molecular recognition. An aptamer-based strategy using DNA for both nanoparticle liganding during growth and protein detection has recently been reported 15 ; the toxicities and hydrodynamic radii of these materials were not investigated, and although the proposed application of the strategy was restricted to a single protein, adsorption of non-target proteins was noted. In summary, although promising advances have already been made, a general approach to high-fidelity biomolecular functionalization of nanocrystals capable of specifically binding to a diverse range of targets has never previously been explored.
We designed a one-pot synthesis that would allow nucleic acids-functionalized nanocrystals to be prepared that would bind a variety of biomolecular targets. The approach relies on the design of chimeric oligonucleotides that contain two different domains-one that will be liganded to the nanocrystal, and one that will be capable of molecular recognition (Fig. 1) . Our demonstration herein of strong and specific binding to a wide diversity of targets-DNA, proteins and cells-stems directly from this chimeric strategy, in which one portion is optimized for liganding, and the other is optimized for interaction with biomolecular targets. To produce one oligonucleotide structure that would be able to contain both types of moieties, we proposed building oligonucleotides containing two different types of backbones with different affinities for metals. Phosphorothioates ( ps), sulphur-containing variants of the usual phosophodiester backbone, were used to provide a ligand structure that would preferentially bind an inorganic surface over phosphates ( po) 16 . Cd 2þ ions are known to exhibit a 3,000-fold preference for sulphur over oxygen binding when presented with nucleotides; thus we believed that this preferential binding would direct the two domains to interact with the nanocrystal surface to very different extents. By including both po and ps backbones in one oligonucleotide, DNA would serve as a ligand for, and an appendage to, the nanocrystal synthesized in its presence.
To produce DNA-functionalized nanocrystals that would be of maximal utility for imaging applications, we developed a synthetic protocol that would yield strongly emissive materials. We took as our starting point a method previously developed for the synthesis of CdTe that uses glutathione (GSH) as a ligand and sulphur source 17 ; the synthesis is compatible with the use of water as a solvent, and is conducted under ambient atmosphere at 100 8C. Given that DNA is stable under these conditions, this appeared to be an ideal strategy for incorporation of DNA as a co-ligand. In the presence of a chimeric ps-po DNA oligonucleotide, the CdTe nanocrystals generated using this approach have desirable emission properties, demonstrating 17% quantum yield and a full-width at half-maximum of 50 nm (Fig. 2a) . The emission spectrum of DNA -CdTe relative to nanocrystals made with GSH alone is blueshifted, indicating that the DNA ligand may interact electronically with the crystal surface and alter its electronic properties. Transmission electron microscopy (TEM) images confirm that the materials are nanoscale, and selected area diffraction (SAD) confirms that they are crystalline (Fig. 2) . The hydrodynamic size of the DNA-functionalized nanocrystals was assessed using gel filtration chromatography (Fig. 2b) . Sizing standards were used to calibrate the experiment and allow for the calculation of diameters (see Supplementary Information). CdTe made with the ps -po oligonucleotide exhibited small hydrodynamic diameters with a narrow size distribution ranging from 6.0 to 6.5 nm as measured by gel filtration chromotagraphy. Those made with GSH alone had diameters of 4.3 to 5.3 nm (see Supplementary Information, Fig. S1 and ref. 17) , illustrating that functionalization was achieved without an excessive increase in the overall size of the nanocrystals. Obtaining nanocrystals in this size range is ideal, as circulation in living systems has been shown to be impeded for structures with larger hydrodynamic diameters 4 .
To examine the role of the ps backbone as a ligand, we also analysed products of syntheses performed with all po oligonucleotides. Interestingly, CdTe synthesized with all po DNA exhibit a much broader size distribution ranging from 4.5 to 7.0 nm (Fig. 2b) . This observation suggests that the ps domain directs the formation of products that are uniformly sized, but, in the absence of this functionality, products with a variety of ligand conformations and orientations are obtained.
The stability of DNA-functionalized CdTe nanocrystals was also assessed to determine whether these materials would withstand different incubation conditions. High pH and high ionic strength were not found to perturb the emission of the nanocrystals, but it was determined that low pH strongly diminished the luminescence (see Supplementary Information) . Nonetheless, the nanomaterials produced are stable under the conditions that would be of most utility for biological studies.
To evaluate the binding of the DNA-passivated CdTe nanocrystals to biomolecular targets, we first tested the hybridization with complementary DNA using gel filtration chromatography (Fig. 3) . The DNA target used contains a 10-nucleotide binding sequence and a 41-nucleotide overhang, and the hybridization was carried out for 60 minutes at room temperature. For the CdTe synthesized with ps -po DNA and hybridized with the DNA target complementary to the po domain, a high level of hybridization was achieved. However, when an all-po DNA oligomer with the same sequence was used for CdTe synthesis, hybridization was strongly diminished. This dramatic difference suggests that it is necessary to incorporate the ps domain into the ligand DNA to allow the po domain to be free for binding. In order to confirm further that the ps domain was more strongly liganded to the nanocrystal than the po domain, the hybridization of a DNA target complementary to the ps portion was monitored. A significant decrease in hybridization efficiency was observed, indicating that most of the ps domains present are interacting with the surface of the nanocrystals as ligands, with the po portion much more accessible for hybridization. DNA targets lacking any complementarity to the ps -po oligonucleotide displayed no binding, confirming that the complexation observed is specific. The number of DNA oligonucleotides available for binding to complementary targets was also assessed by titrating DNA -CdTe with differing stoichiometries of complement, and it was found, interestingly, that only one DNA sequence is available for binding per nanocrystal (Fig. 3c) .
The binding of DNA-functionalized CdTe to protein targets was also explored. We used the thrombin binding aptamer (TBA) to explore the binding of a model protein target. This aptamer was discovered using in vitro selection and folds into a G-quartet structure which binds to either the fibrinogen recognition exosite or the heparin binding site of thrombin 18, 19 . Thus, we designed a chimeric DNA oligonucleotide with TBA as the po-based recognition domain and a ps portion as the ligand domain ( ps -po -TBA). This chimeric DNA was used as a co-ligand during synthesis and the binding of CdTe with thrombin was then monitored by gel filtration chromatography. As shown in Fig. 4 , the nanocrystals synthesized with ps-po-TBA exhibit the highest binding level towards thrombin and there is no non-specific binding of thrombin to the CdTe synthesized with a scrambled DNA aptamer ( ps-po-X). When all po -TBA is used to replace ps-po -TBA for CdTe synthesis, a much lower binding level is observed, but it is higher than the binding to DNA shown in Fig. 3 . However, this small amount of binding appears to be non-specific, as when binding of all po CdTe to bovine serum albumin (BSA) was evaluated, significant complexation was observed (see Supplementary Information) that was much higher than obtained when a ps-po sequence was used for synthesis. It is likely that the high levels of non-specific adsorption result from displacement of the poorly bound DNA phosphate ligands by protein residues. These results further illustrate that integrating a ps domain, with the phosphorothioate providing strongly bound ligands that are less susceptible to displacement, into a DNA ligand is important in the generation of bioactive and specific CdTe.
The results of research aimed at constructing DNA-passivated CdTe with high fidelity and specificity toward nucleic acids and protein targets suggests that, potentially, these materials could be applied to much more complicated systems such as live cells for imaging and diagnostic applications. To test the suitability of our materials for this application, we examined DNA-programmed CdTe nanocrystals functionalized with a cancer-cell binding aptamer. These recently discovered aptamers represent an attractive alternative to routinely used antibodies because of their small sizes, chemical robustness and ease of synthesis [20] [21] [22] [23] . We selected an aptamer previously shown to exhibit selective affinity to CCRF-CEM cells (T cell line, human acute lymphoblastic leukaemia) versus Ramos cells (B cell line, human Burkitt's lymphoma). To functionalize our CdTe with the cell binding aptamer, a ps -po DNA oligomer was used to synthesize CdTe, and then the cellbinding aptamer carrying a sequence complementary to the po portion was introduced to CdTe through hybridization. Binding with live CCRF-CEM cells and Ramos cells was then monitored by flow cytometry and fluorescence microscopy. As shown in Fig. 5 , the aptamer-functionalized CdTe exhibits detectable discrimination between the two cell types. Importantly, we confirmed that the aptamer is responsible for the cell-type discrimination by also monitoring the construct lacking the hybridized aptamer or made with an all po sequence (Fig. 5c) ; these materials did not exhibit appreciable differential binding to the two cell types. Fluorescence imaging of aptamer-functionalized CdTe also shows qualitatively that there is differential binding to CCRF-CEM and Ramos cells. These results indicate that using a one-pot aqueous synthesis with simple and accessible materials, imaging agents can be prepared that are cell-type specific.
The applicability of these DNA-functionalized CdTe nanocrystals to biological studies requires that their presence have a minimal effect on cellular function and viability. To assess directly the toxicity of our materials, we monitored the viability of the CCRF-CEM cells that are specifically bound by aptamer-modified CdTe. No appreciable cell death was observed (see Supplementary Information), indicating that the materials are stable and not prone to releasing components when introduced into biological media.
In summary, we have developed a strategy that allows the simultaneous synthesis and functionalization of CdTe nanocrystals through a convenient one-pot process by using chimeric DNA molecules as ligands. These DNA-passivated nanocrystals exhibit high specific binding to nucleic acids, protein and cell targets. Moreover, they are non-toxic and possess small hydrodynamic radii; these are essential qualities for biological imaging applications.
Methods
Materials. Cadmium sulphide, tellurium powder, sodium borohydride, GSH and human a-thrombin were purchased from Sigma-Aldrich and used as received. DNA was purchased from Integrated DNA Technologies. Protein standards for nanocrystals sizing including blue dextran, thyroglobulin, BSA and lysozyme were from Sigma-Aldrich. CCRF-CEM (CCL-119, T-cell line, human ALL) and Ramos (CRL-1596, B cell line, human Burkitt's lymphoma) were from American Type Culture Collection (ATCC). Both cell lines were cultured in RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum (GIBCO) and 100 units ml 21 penicillin -streptomycin (Cellgro) in a humidified incubator at 37 8C containing 5% CO 2 . Cell binding buffer was prepared by dissolving 0. Functionalized CdTe synthesis and characterization. Sodium hydrogen telluride (NaHTe) was freshly made before each synthesis by dissolving 0.025 g sodium borohydride (NaBH 4 ) in 1 ml deionized water and then 0.040 g tellurium powder was added into the NaBH 4 solution. This reaction was conducted at room temperature overnight in an eppendorf tube with a needle (21G1 1 / 2 , BD) inserted through the lid to help release the gas generated during the reaction. CdCl 2 -GSH stock solution was made to include 1.25 mM CdCl 2 and 1.05 mM GSH in H 2 O and pH was adjusted to 9.0 with sodium hydroxide before use. For a typical CdTe synthesis, 400 ml CdCl 2 -GSH stock solution was mixed with 0.8 ml of freshly prepared NaHTe solution in a 0.7 ml eppendorf tube and then DNA solution containing 120 nmol nucleotides was added. The reaction was conducted on a heat block (Fisher Scientific) at 100 8C for 1 h and then gradually cooled to room temperature. The absorption and emission spectra of CdTe were taken on Agilent 8453 absorption spectrophotometer and HR2000 fibre optic emission spectrometer, respectively. Quantum yields were measured using 9,10-diphenylanthracene (Sigma) in hexane as a relative standard with an excitation wavelength of 375 nm and an integrated emission between 380 and 900 nm. For nanocrystals sizing, a protein standards solution was prepared to include 15 ml blue dextran (25 mg ml 21 ), 35 ml thyroglobulin (25 mg ml 21 ), 25 ml BSA (25 mg ml
21
) and 10 ml lysozyme (25 mg ml
). Gel filtration chromatography was run using a Superose 10/300GL column (Amersham). The flow rate was fixed at 0.35 ml min 21 and each sample ran for an overall time of 80 min. The wavelength used to monitor nanocrystals was set at 370 nm and recorded by HP 1100 HPLC system. 1Â Dulbecco's PBS (pH 7.4) was used as running buffer.
Transmission electron microscopy and selected area diffraction. TEM images were taken using Hitachi HD-2000 scanning transmission electron microscope (STEM) in annular dark-field mode at 200 kV. CdTe QDs were filtered through Microcon YM-50 centrifugal filters and resuspended in water to remove free ligands and then 5 ml of sample was dispensed onto a 3 mm copper grid covered with a continuous carbon film. The samples were air-dried at room temperature.
Binding of nanocrystals with DNA and protein targets. The quantitation of CdTe-DNA was performed using an approximate extinction coefficient of 200,000 cm 21 M 21 at 520 nm according to ref. 24 . Free DNA targets were quantitated using an extinction coefficient of 489,700 cm 21 M 21 at 260 nm. For DNA binding, 1.5-fold excess DNA targets were added into CdTe-containing solutions and left at room temperature for 1 h before gel filtration chromatography measurements. For protein binding, human a-thrombin and BSA were dissolved in 1Â Dulbecco's PBS and 1.5-fold excess protein targets were added into CdTe solutions containing 0.5Â Dulbecco's PBS, which was then incubated at 37 8C for 1 h. The binding was monitored by gel filtration chromatography and the binding fraction was calculated by integrating the area of each peak. For binding of nanocrystals with cells, to functionalize CdTe with a cell-binding aptamer, CdTe synthesized with ps-po DNA (400 ml) were first purified using a Microcon YM-50 centrifugal filter (8,000g, 10 min) to remove excess DNA and ions. Then the CdTe particles were resuspended in 400 ml of 10 mM MgCl 2 solution containing 4 mM cell binding aptamer carrying the sequence complementary to the po portion. The hybridization reaction was carried out at room temperature for 1 h. Functionalized CdTe were buffer exchanged using a Microcon YM-50 centrifugal filter by resuspending the CdTe in 400 ml cell binding buffer. For each binding, 1 Â 10 6 cells were suspended in 400 ml CdTe solution and incubated at 4 8C for 1 h. Unbound CdTe was removed by spinning down the cell suspension and the cells were washed twice with ice-cold cell binding buffer. The cell binding was monitored using a BD FACSCalibur flow cytometer with 488 nm laser excitation. CdTe synthesized with GSH alone was used to evaluate background binding. The CdTe synthesized with ps-po DNA without further functionalization were used as non-cognate aptamer binding control.
Confocal microscopy. 1 Â 10 5 CCRF-CEM or Ramos cells were suspended in 300 ml cell binding buffer containing 200 nM of cell-binding aptamer-functionalized CdTe and incubated at 4 8C for 1 h. The cells were then recollected by centrifugation and washed twice with ice-cold cell binding buffer. The photoluminescence images were obtained with a Zeiss LSM 510 confocal microscope using a Â63 water immersion objective with 488 nm argon laser excitation and the emission was collected with a 505 nm long-pass filter. Microscope settings were adjusted to eliminate autofluorescence and kept constant during acquisition.
